Kleanthis Xanthopoulos, a veteran of the San Diego biotech scene, said he expects his latest venture, IRRAS AB, to be profitable by 2018.

Kleanthis Xanthopoulos, a veteran of the San Diego biotech scene, said he expects his latest venture, IRRAS AB, to be profitable by 2018.

— The growth of San Diego’s biotech hub is often credited to a small but active pool of “serial entrepreneurs...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129